You are here

Article Text

Article menu
Download PDFPDF
Case Report
Sufentanil Stellate Ganglion Injection in the Treatment of Refractory Reflex Sympathetic Dystrophy
  1. Lorraine M. Arias, M.D.*,
  2. Richard Bartkowski, M.D.†,
  3. Karen L. Grossman, R.N.‡,
  4. Robert J. Schwartzman, M.D.§ and
  5. Carol Mei-Lin Tom, M.D.∥
  1. From the Departments of Anesthesiology and Neurology, Jefferson Medical College, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
  2. *Director of Pain Center. Instructor of Anesthesiology
  3. †Associate Professor of Anesthesiology
  4. ‡Research Nurse
  5. §Professor and Chairman of Neurology
  6. ∥Fellow of Anesthesiology

Abstract

Reflex sympathetic dystrophy is a neurologic disorder with characteristic symptomatology including burning dysesthesia, swelling, and vasomotor alteration. Two patients with refractory reflex sympathetic dystrophy underwent stellate ganglion injection with 10 mcg of sufentanil in 10 ml preservative-free saline. Both reported decrease in pain and improved mobility, which was long lasting.

  • Reflex Sympathetic Dystrophy
  • Stellate Ganglion Injection
  • Sufentanil
  • Opiate receptors

https://doi.org/10.1136/rapm-00115550-198914020-00011

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.